SFU
MDXG icon

Stonehage Fleming (UK)’s MiMedx Group MDXG Stock Holding History

Stonehage Fleming (UK)’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,574
Closed -$18K – 231
2014
Q4 		$18K Buy
+1,574
New +$15.5K 0.01% 264

Other funds holding MDXG

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Stonehage Fleming (UK)'s MDXG Position: Q1 2015 in Review

Stonehage Fleming (UK) sold out of MiMedx Group (MDXG) in Q1 2015, closing a stake of 1,574 shares — an estimated $18K sold.

Stonehage Fleming (UK) first reported a position in MDXG in Q4 2014 and held it in 1 quarter. The position peaked at $18K in Q4 2014. 147 funds tracked by Wall St. Rank hold MDXG as of Q1 2015.

  • Stonehage Fleming (UK) reported no remaining MiMedx Group position as of Q1 2015 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 1,574 MiMedx Group shares in Q1 2015, an estimated $18K.
  • Stonehage Fleming (UK) first reported a position in MiMedx Group in Q4 2014 and held it in 1 quarter.
  • Stonehage Fleming (UK)'s MiMedx Group position peaked at $18K in Q4 2014.
  • 147 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q1 2015, filed 11 Oct 2019.